{
  "meta": {
    "title": "Neoplasia",
    "url": "https://brainandscalpel.vercel.app/neoplasia-17847619.html",
    "scrapedAt": "2025-11-30T08:50:29.746Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Capillary hemangioma</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Peutz jeghers polyps</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Benign cartilaginous tumor</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreatic tissue found in the submucosa of stomach</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an example of Choriostoma? </span></p>",
      "unique_key": "DT1313553",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313553,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Hamartomas </strong>:- A disorganized overgrowth of normal tissue in its normal location\n<ul>\n<li>Pulmonary hamartoma</li>\n<li>Capillary hemangioma</li>\n<li>Peutz jeghers polyp</li>\n</ul>\n</li>\n<li><strong>Choriostoma :- </strong>Normal tissue growth in an abnormal location\n<ul>\n<li>Pancreatic choriostoma in liver or stomach</li>\n</ul>\n</li>\n<li>Benign cartilaginous tumors are not choriostoma. Examples- Osteochondroma, enchondroma, chondroblastoma.</li>\n</ul>\n<p><strong>KEY TAKEAWAYS: </strong>Choristoma is a congenital, benign growth of normal tissue located in an abnormal location. It is not neoplastic but represents ectopic tissue development.</p>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">No signs of metastasis</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Non cohesive, infiltrating mass</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Progressive and slow</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Well differentiated</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Features following benign tumours are all; except</span></p>",
      "unique_key": "DT1313554",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313554,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Benign tumors are non-cancerous growths that remain localized and generally do not invade surrounding tissues or metastasize to distant sites.</p>\n<p>Gross Features:</p>\n<ol>\n<li>Well-Circumscribed:\n<ul>\n<li>Clearly demarcated boundaries.</li>\n<li>Often <strong>encapsulated with a fibrous capsule.</strong></li>\n</ul>\n</li>\n<li>Slow Growth:\n<ul>\n<li>Enlarges gradually over time.</li>\n<li>Growth rate is usually predictable.</li>\n</ul>\n</li>\n<li>Localized:\n<ul>\n<li><strong>Does not infiltrate surrounding tissues.</strong></li>\n<li>Remains at the site of origin.</li>\n</ul>\n</li>\n<li>Non-Metastatic:\n<ul>\n<li>Does not spread to distant organs via lymphatics or blood<strong>.</strong></li>\n</ul>\n</li>\n</ol>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123e07d2bdc-34b5-4e92-8c05-4823098e1bb5.jpg\">\n<p><strong>KEY TAKEAWAYS:</strong></p>\n<p>Microscopic Features of Benign tumors:</p>\n<ol>\n<li><strong>Cellular Differentiation:</strong>\n<ul>\n<li>Cells closely resemble their tissue of origin (well-differentiated).</li>\n<li>Normal nucleus-to-cytoplasm ratio.</li>\n</ul>\n</li>\n<li><strong>Low Mitotic Activity:</strong>\n<ul>\n<li>Rare mitotic figures, and if present, they appear normal.</li>\n</ul>\n</li>\n<li><strong>Absence of Invasion:</strong>\n<ul>\n<li>Cells do not infiltrate the basement membrane or surrounding tissues.</li>\n</ul>\n</li>\n<li><strong>Lack of Necrosis:</strong>\n<ul>\n<li>Minimal or no areas of necrosis within the tumor.</li>\n</ul>\n</li>\n</ol>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Seeding of peritoneal cavity</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphatic spread</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Haematogenous spread</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the following gross image of omentum, through which pathway it might be involved by metastatic ovarian carcinoma? <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501239cfe53c8-f292-44dc-b37f-f398fd09867e.jpg\"></span></p>",
      "unique_key": "DT1313556",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313556,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Dissemination of cancers</strong> occurs through three pathways:\n<ol>\n<li>Direct seeding of body cavities or surfaces</li>\n<li>Lymphatic spread</li>\n<li>Hematogenous spread</li>\n</ol>\n</li>\n<li><strong><u>Seeding of Body Cavities and Surfaces.</u></strong> (Choice A)\n<ul>\n<li>occurs when a malignant neoplasm <strong><u>penetrates into a natural \"open field\" lacking physical barriers. </u></strong></li>\n<li>Most often involved is the peritoneal cavity but pleural, pericardial, subarachnoid, and joint spaces-may be affected.</li>\n<li><strong>Such seeding is particularly characteristic of carcinomas arising in the ovaries, which often spread to peritoneal surfaces, producing a heavy cancerous coating</strong>.</li>\n<li>The tumor cells may remain confined to the surface of the abdominal viscera without penetrating into the substance. Sometimes, mucus-secreting appendiceal carcinomas or ovarian carcinomas fill the peritoneal cavity with a gelatinous neoplastic mass referred to as pseudomyxoma peritonei.</li>\n</ul>\n</li>\n<li><strong><u>Lymphatic spread</u></strong> (choice B)\n<ul>\n<li>Example :- Axillary lymph node metastasis in breast cancer</li>\n</ul>\n</li>\n<li><strong><u>Hematogenous spread</u></strong> (choice C)\n<ul>\n<li>Hematogenous spread is typical of <strong>sarcomas</strong> but is also seen with <strong>carcinomas</strong>.</li>\n<li>The liver and the lungs are most frequently involved by hematogenous dissemination because all portal area drainage flows to the liver and all caval blood Flows to the lungs.</li>\n</ul>\n</li>\n</ul>\n<p><strong>KEY TAKEAWAYS:</strong> <strong>Dissemination of cancers</strong> occurs through three pathways:</p>\n<ol>\n<li>Direct seeding of body cavities or surfaces</li>\n<li>Lymphatic spread</li>\n<li>Hematogenous spread</li>\n</ol>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">A- I, B- IV, C- III, D- II</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">A- III, B-I, C-II, D-IV</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">A-II, B-III, C- IV, D-I</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">A-IV, B- III, C- II, D- I</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the occupational agents causing particular cancer. <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025012347445a02-77b8-4eba-9c4d-895ea52cc71b.png\"></span></p>",
      "unique_key": "DT1313557",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313557,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123ad60848b-838c-413e-936d-f750986e2102.jpg\"><br>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025012373d77de3-e1e9-46ad-912c-6d727de2e341.png\">",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">KRAS</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">MYC</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">ABL</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">NOTCH1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following proto-oncogene example of nonreceptor tyrosine kinase?</span></p>",
      "unique_key": "DT1313558",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313558,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Nonreceptor Tyrosine Kinases. </strong></p>\n<ul>\n<li>Oncogenic mutations also occur in several <strong><u>nonreceptor tyrosine kinases </u>that <u>normally localize to the cytoplasm or the nucleus</u></strong><u>.</u></li>\n<li>The mutations take the form of chromosomal translocations or rearrangements that create fusion genes encoding constitutively active tyrosine kinases.</li>\n<li>Despite their nonmembranous localization, these oncoproteins seem to activate the same signaling pathways as receptor tyrosine kinases.</li>\n<li>An important example of this oncogenic mechanism involves the <strong>ABL tyrosine kinase.</strong></li>\n<li>In <strong>chronic myeloid leukemia (CML)</strong> and a subset of acute lymphoblastic leukemia, the ABL gene is translocated from its normal abode on chromosome 9 to chromosome 22, where it fuses with the BCR gene.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123401b2387-1707-4d38-b459-298274eac832.jpg\">\n<p><strong>KEY TAKEAWAYS</strong>: <strong>ABL1 (Proto-Oncogene c-Abl)</strong></p>\n<ul>\n<li><strong>Function</strong>: Encodes a cytoplasmic and nuclear tyrosine kinase that regulates DNA damage response, cell adhesion, and cell cycle.</li>\n<li><strong>Notable Fusion</strong>: The BCR-ABL1 fusion protein (resulting from the Philadelphia chromosome in chronic myeloid leukemia) is a constitutively active tyrosine kinase, leading to malignancy.</li>\n</ul>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">A- IV, B- III, C- II, D- I</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">A- II, B- III, C- I, D- IV</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">A- III, B-I, C- IV, D- II</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">A- II, B-IV,  C- I, D-III</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the correct cellular and molecular hallmarks of cancer to their functions.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123970e86c9-854c-47de-956e-c395c705ace5.png\"></span></p>",
      "unique_key": "DT1313559",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313559,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>All cancers display <strong>eight</strong> fundamental changes in cell physiology, which are considered the <strong><u>hallmarks of cancer. </u></strong>These consist of the following:</p>\n<ol>\n<li><strong><u>Self-sufficiency in growth signals. </u></strong>\n<ul>\n<li>Tumors have the capacity to proliferate without external stimuli, usually as a consequence of <em><u>oncogene activation</u></em></li>\n</ul>\n</li>\n<li><strong><u>Insensitivity to growth-inhibitory signals.</u></strong>\n<ul>\n<li>Tumors may not respond to molecules that inhibit the proliferation of normal cells, usually because of <em><u>inactivation of tumor suppressor genes</u></em> that encode components of growth inhibitory pathways.</li>\n</ul>\n</li>\n<li><strong><u>Altered cellular metabolism.</u></strong>\n<ul>\n<li>Tumor cells undergo a metabolic switch to <strong>aerobic glycolysis (called the <em><u>Warburg effect),</u></em></strong> which enables the synthesis of the macromolecules and organelles that are needed for rapid cell growth.</li>\n</ul>\n</li>\n<li><strong><u>Evasion of apoptosis. </u></strong>\n<ul>\n<li>Tumors are resistant to programmed cell death.</li>\n</ul>\n</li>\n<li><strong><u>Limitless replicative potential (immortality).</u></strong>\n<ul>\n<li>Tumors have unrestricted proliferative capacity, a <em><u>stem cell&ndash;like property</u></em> that permits tumor cells to avoid cellular senescence and mitotic catastrophe.</li>\n</ul>\n</li>\n<li><strong><u>Sustained angiogenesis.</u></strong>\n<ul>\n<li>Tumor cells need a vascular supply to bring nutrients and oxygen and remove waste products. Hence, tumors must induce angiogenesis.</li>\n</ul>\n</li>\n<li><strong><u>Ability to invade and metastasize.</u></strong>\n<ul>\n<li>Tumor metastases are the cause of the vast majority of cancer deaths</li>\n</ul>\n</li>\n<li><strong><u>Ability to evade the host immune response. </u></strong>\n<ul>\n<li>Cancer cells exhibit a number of alterations that allow them to evade the host immune response</li>\n</ul>\n</li>\n</ol>\n<p><strong>Key Takeaways:</strong> Cancer hallmarks include self-sufficiency in growth signals, insensitivity to growth inhibitors, altered metabolism (Warburg effect), evasion of senescence, and others.</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic myeloid leukemia</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Burkitt lymphoma</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute lymphoblastic leukemia</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Mantle cell lymphoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">From the following image of chromosomal translocation and associated oncogene, choose the correct diagnosis for red box. <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123b321f62d-baf8-4583-8db2-420ca30a86ee.jpg\"></span></p>",
      "unique_key": "DT1313560",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313560,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>In Burkitt lymphoma, the MYC gene is translocated into an antigen receptor gene locus, which contains gene regulatory elements called enhancers that are highly active in lymphocytes.</p>\n<ul>\n<li>Burkitt lymphoma is an aggressive B-cell non-Hodgkin lymphoma characterized by <strong>MYC gene dysregulation</strong>.</li>\n<li>The hallmark of this malignancy is the translocation of the <strong>MYC proto-oncogene</strong> on chromosome 8 to regions under the control of immunoglobulin (Ig) gene enhancers.</li>\n</ul>\n<p><strong>Pathophysiology</strong></p>\n<ul>\n<li>The Ig enhancers drive <strong>constitutive overexpression</strong> of MYC, leading to:\n<ol>\n<li><strong>Uncontrolled Cell Proliferation</strong>:\n<ul>\n<li>MYC upregulates cyclins and other genes promoting the cell cycle.</li>\n</ul>\n</li>\n<li><strong>Inhibition of Apoptosis</strong>:\n<ul>\n<li>Interferes with apoptotic pathways, such as through downregulation of BCL-2 inhibitors.</li>\n</ul>\n</li>\n<li><strong>Metabolic Reprogramming</strong>:\n<ul>\n<li>Increases glycolysis and biosynthesis to support rapid cell division.</li>\n</ul>\n</li>\n</ol>\n</li>\n</ul>\n<p><strong>KEY TAKEAWAYS</strong>: In Burkitt lymphoma, translocations involving the <strong>MYC gene</strong> lead to its dysregulated overexpression, driving tumorigenesis. Prompt diagnosis through cytogenetic and molecular testing is critical for initiating effective therapy.</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Cowden syndrome</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Gorlin syndrome</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Peutz jeghers syndrome</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Li fraumeni syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which condition is seen in germline mutation of STK11 from the following? </span></p>",
      "unique_key": "DT1313561",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313561,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>The STK11 gene, </strong>also known as LKB1</p>\n<ul>\n<li>Encodes a serine/threonine kinase that is an important regulator of cellular metabolism.</li>\n<li>Germline loss-of-function STK11 mutations cause <strong>Peutz-Jeghers syndrome</strong>, an <strong><em><u>autosomal dominant disorder</u></em></strong> associated with benign polyps of the gastrointestinal tract and an increased risk of multiple epithelial cancers, particularly gastrointestinal and pancreatic carcinomas.</li>\n<li><strong>STK11 has pleiotropic effects on multiple facets of cellular metabolism including glucose uptake, gluconeogenesis, protein synthesis, mitochondrial biogenesis, and lipid metabolism</strong>.</li>\n<li>Sporadic STK11 loss-of-function mutations are found in diverse carcinomas, a finding pointing to the important role of altered cellular metabolism in the establishment and maintenance of the transformed state.</li>\n</ul>\n<p><strong>KEY TAKEAWAYS</strong>: The <strong>STK11 gene</strong> plays a pivotal role in maintaining cellular energy balance, polarity, and tumor suppression. Germline mutations cause Peutz-Jeghers Syndrome, while somatic mutations are implicated in several aggressive cancers</p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">A- IV, B- III, C-II, D-I</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">A- III, B-I, C- II, D- IV</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">A- II, B-I III, C- IV, D-I</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">A- IV, B-I, C- III, D-II</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following cell cycle components with appreciate functions. <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123c0d5c827-3c5c-4b1b-92b8-07815565bf24.png\">\r\n</span></p>",
      "unique_key": "DT1313562",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313562,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123ace30a8a-b316-4ea4-aa07-0fe1b32f5e6b.jpg\">",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Bloom syndrome</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Ataxia telangiectasia</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Fanconi anemia</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">HNPCC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not an example of homologous recombination repair? </span></p>",
      "unique_key": "DT1313563",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313563,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><u>HOMOLOGOUS RECOMBINATION REPAIR FACTORS</u></strong>. Other types of DNA damage, particularly <strong>covalent DNA cross-links and double-stranded DNA breaks</strong>, are repaired through a complex process called homologous recombination. Several disorders caused by defects in homologous recombination factors are associated with an increased risk of cancer, as follows:</p>\n<ul>\n<li><strong><u>Bloom syndrome:- (choice A) </u></strong>\n<ul>\n<li>Autosomal recessive disorder</li>\n<li>Loss-of-function mutations in a helicase that is required for homologous recombination repair.</li>\n</ul>\n</li>\n<li><strong>Ataxia telangiectasia</strong> (choice B)\n<ul>\n<li>Autosomal recessive disorder caused by defects in atm, a gene encoding a kinase that acts upstream of p53</li>\n<li>Neurodegeneration, immunodeficiency, hypersensitivity to radiation, and predisposition to cancer, particularly certain forms of leukemia and lymphoma.</li>\n</ul>\n</li>\n<li><strong>Fanconi anemia (choice C) </strong>\n<ul>\n<li>Autosomal recessive disorder</li>\n<li>Mutations in more than a dozen different genes,</li>\n<li>It is characterized by developmental abnormalities, hypersensitivity to chemotherapeutic agents that cross-link dna, and increased risk of bone marrow failure (aplasia) and leukemia.</li>\n</ul>\n</li>\n<li><strong><u>Familial breast cancer </u></strong>\n<ul>\n<li>Mutations in two genes, brca1 and brca2, account for 25% of cases. Certain germline brca2 mutations cause fanconi anemia, and it appears that brca proteins and fanconi proteins function cooperatively in a dna damage response network linked to homologous recombination repair.</li>\n</ul>\n</li>\n</ul>\n<p><strong>KEY TAKEAWAYS</strong>: <strong><u>HNPCC</u></strong> :- Hereditary nonpolyposis colon cancer (HNPCC) syndrome (also Known as Lynch syndrome) (choice D)</p>\n<p><strong>Autosomal dominant</strong> disorder associated with carcinomas that arise predominantly in the cecum and proximal colon. It is a <strong>DNA mismatch repair </strong>disorder<strong>.</strong></p>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">p53, p26</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">p53, p21</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">p21, RB</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">TERT, p53</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">HPV E6 & E7 proteins bind to which genes respectively:</span></p>",
      "unique_key": "DT1313564",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313564,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Role of E6 Protein</strong></p>\n<ul>\n<li><strong>p53 Degradation:</strong>\n<ul>\n<li>E6 binds to the cellular E3 ubiquitin ligase E6AP (E6-associated protein).</li>\n<li><strong>Targets p53, the tumor suppressor, for proteasomal degradation.</strong></li>\n<li>Result: Loss of p53-mediated apoptosis and DNA damage response.</li>\n</ul>\n</li>\n<li><strong>Telomerase Activation:</strong>\n<ul>\n<li><strong>E6 upregulates hTERT (human telomerase reverse transcriptase).</strong></li>\n<li>Leads to telomere maintenance and cellular immortality.</li>\n</ul>\n</li>\n<li><strong>Evasion of Apoptosis</strong>:\n<ul>\n<li>Inhibits pro-apoptotic proteins (e.g., BAK) to promote cell survival.</li>\n</ul>\n</li>\n<li><strong>Immune Evasion</strong>:\n<ul>\n<li>Downregulates immune-related pathways, including interferon responses.</li>\n</ul>\n</li>\n</ul>\n<p><strong>3. Role of E7 Protein</strong></p>\n<ul>\n<li><strong>RB Pathway Inactivation:</strong>\n<ul>\n<li>E7 binds to and degrades retinoblastoma protein (RB).</li>\n<li><strong>Releases E2F transcription factors, promoting uncontrolled cell cycle progression</strong>.</li>\n<li>Drives the cell from the G1 phase into the S phase, even in the absence of growth signals.</li>\n</ul>\n</li>\n<li><strong>Epigenetic Changes</strong>:\n<ul>\n<li>Modulates chromatin structure and transcription to favor oncogenic gene expression.</li>\n</ul>\n</li>\n<li><strong>Centrosome Abnormalities:</strong>\n<ul>\n<li>Induces centrosome duplication errors, leading to aneuploidy and genomic instability.</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025012349375092-fb5a-4bd3-8e2f-42dec735ed38.jpg\">\n<p><strong>KEY TAKEAWAYS:</strong> The HPV E6 and E7 oncoproteins are central to HPV-associated carcinogenesis. By targeting p53 and RB pathways, these proteins disrupt cell cycle regulation, inhibit apoptosis, and promote immortalization, leading to malignancy.</p>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of fat that cannot be explained by diminished food intake</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of muscle mass and fat that can be explained by diminished food intake</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of muscle mass that can be explained by diminished food intake</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of muscle mass that cannot be explained by diminished food intake</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is correctly said about cancer cachexia from the following? </span></p>",
      "unique_key": "DT1313565",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313565,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><u>Cancer cachexia</u></strong> :- it is a hypercatabolic state defined by a <strong>LOSS OF MUSCLE MASS (WITH OR WITHOUT LOSS OF FAT) THAT CANNOT BE EXPLAINED BY DIMINISHED FOOD INTAKE. </strong></p>\n<p>It occurs in about 50% of cancer patients, most commonly in individuals with advanced gastrointestinal, pancreatic, and lung cancers, and is responsible for about 30% of cancer deaths.</p>\n<p>It is a highly debilitating condition characterized by extreme weight loss, fatigue, muscle atrophy, anemia, anorexia, and edema. Mortality is generally the consequence of atrophy of the diaphragm and other respiratory muscles.</p>\n<p><strong>KEY TAKEAWAYS</strong>: It is a hypercatabolic state defined by a <strong>LOSS OF MUSCLE MASS (WITH OR WITHOUT LOSS OF FAT) THAT CANNOT BE EXPLAINED BY DIMINISHED FOOD INTAKE.</strong></p>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">A- II, B- III, C-IV, D- I</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">A- III, B-II, C- I, D- IV</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">A- II, B-I, C-IV, D- III</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">A- I, B-IV, C-II, D- III</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the paraneoplastic syndromes with its respective underlying cancer. <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123d921179e-6301-4b34-b676-bfb64fa4effb.png\"></span></p>",
      "unique_key": "DT1313566",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313566,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025012306e1501d-1220-4717-a63c-ea96428e3792.jpg\">",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Membranous, epithelial origin</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Cytoplasmic, mesenchymal origin</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Cytoplasmic, epithelial origin</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Membranous, mesenchymal origin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which type of immunoreactivity is shown in the following microscopic image of the pancytokeratin immunohistochemistry marker and it points towards what type of origin? <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123f7e9b696-788c-4113-8f03-db7f9acf8727.jpg\"></span></p>",
      "unique_key": "DT1313567",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313567,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Immunohistochemistry.</strong></p>\n<p>The utility of immunohistochemistry in the diagnosis or management of malignant Neoplasms follow.</p>\n<ul>\n<li><strong>Categorization of undifferentiated malignant tumors </strong></li>\n<li>The presence of <strong>cytokeratins</strong>, <strong>membranous</strong> immunoreactivity detected by immunohistochemistry, points to an <strong>epithelial origin</strong> (carcinoma), whereas desmin is specific for neoplasms of muscle cell origin, and hematologic malignancies lack these cytoskeletal structures. Other useful immunohistochemical markers include lineage-specific membrane proteins (e.g., CD20, a marker of B-cell tumors) and transcription factors.</li>\n<li><strong>Determination of site of origin of metastatic tumors.</strong></li>\n<li>Prostate-specific antigen (PSA) and thyroglobulin are markers of carcinomas of the prostate and thyroid, respectively.</li>\n<li><strong>Detection of molecules that have prognostic or therapeutic significance. </strong></li>\n<li>Immunohistochemical detection of hormone (estrogen/progesterone) receptors in breast cancer cells is of prognostic and therapeutic value because these cancers are susceptible to antiestrogen therapy</li>\n</ul>\n<p><strong>Key Takeaways:</strong> Immunohistochemistry helps identify tumor cell types by detecting specific markers on the tumor cells. For example, <strong>cytokeratins</strong> indicate epithelial origin (carcinomas), <strong>desmin</strong> is specific for muscle cell origin, and <strong>CD20</strong> marks B-cell tumors. It aids in categorizing undifferentiated tumors, determining the site of origin for metastatic tumors, and detecting molecules of prognostic or therapeutic significance, such as hormone receptors in breast cancer.</p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}